Recent Publications 2022-2024

477. Chitosan derivatives as dynamic coatings for transferrin glycoform separation in capillary electrophoresis, Porpiglia, NM, Tagliaro I, Pellegrini B, Antonini C, Bertini S. Int J Biol Macromol, 2024, 254, 127888.

476. A novel biomimetic probe for galectin‐3 recognition: Chemical synthesis and structural characterization of a β‐galactose branched sodium hyaluronate. Nizzolo S, Esposito E, Ni M, Bertocchi L, Bianchini G, Freato N, Zanzoni S, Guerrini M, Bertini S. Proteoglycan Res. 2024;2:e19.

475. Carbohydrate-based antithrombotics. Bisio A., Guerrini G., Naggi A. Chapter in Carbohydrate-Based Therapeutics, Adamo R. and Lay L. Eds., 2024 Wiley-VCH, Weinheim, 353-380.

474. Characterization of Cyclodextrin Cross-linked Polymers Used in Environmental Applications by Solid-state NMR Spectroscopy: a Historical Review. Lacalamita D, Bertini S, Mongiovì C, Cosentino C, Crini N, Torri G, Fourmentin M, Naggi A, Formentin S, Guerrini M, Crini G. in The Environment in a Magnet Applications of NMR Techniques to Environmental Problems, 2024; DOI: 10.1039/BK9781837671250-00316.

473. Differential Solvent DEEP-STD NMR and MD Simulations Enable the Determinants of the Molecular Recognition of Heparin Oligosaccharides by Antithrombin to Be Disentangled. Parafioriti, M., Elli, S., Muñoz-García, J. C., Ramírez-Cárdenas, J., Yates, E. A., Angulo, J., Guerrini, M. (2024). Int J Mol Sci, 25(9), 4669.

472.Different Drug Mobilities in Hydrophobic Cavities of Host–Guest Complexes between β-Cyclodextrin and 5-Fluorouracil at Different Stoichiometries: A Molecular Dynamics Study in Water. Raffaini G, Elli S, Catauro M, D’Angelo A. Int. J. Mol. Sci. 2024, 25, 5888.

471. Chitosan derivatives as dynamic coatings for transferrin glycoform separation in capillary electrophoresis. Porpiglia N.M., Tagliaro I., Pellegrini B., Alessi A., Tagliaro F., Russo L., Cadamuro F., Musile G., Antonini C., Bertini S. International Journal of Biological Macromolecules, Volume 254, Part 2, January 2024, 127888

470. Molecular modeling and phylogenetic analyses highlight the role of amino acid 347 of the N1 subtype neuraminidase in influenza virus host range and interspecies adaptation. Elli S, Raffaini G, Guerrini M, Kosakovsky Pond S and Matrosovich M (2023) Front. Microbiol. 14:1309156. doi: 10.3389/fmicb.2023.1309156

469. Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1)–a promising target for the immunotherapy of cancer. Lopez V, Schuh HM, Mirza S, Vaaßen VJ, Schmidt MS, Sylvester K, Naggi A,   Scheffler B,  Lee S-Y,  Bendas G, Müller CE. Frontiers in Immunology, 2023., 14, 1173634.

468. Development of a cascade production system finalized to the extraction of all-tomatine-rich fraction using the tomato cannery waste as feedstock Abbasi-Parizad P, Salvino RA, Passera A , Follador ARV , Cosentino C, Jucker C, Savoldelli S , Bacenetti J, Casati P , Scaglia B. Journal of Cleaner Production 2023, 401, 136743

467. Blended heparin: a new perspective to guarantee the supply of a life-saving drug? Guerrini M. Clinical and Applied Thrombosis/Hemostasis 2023, 29, 1-2.

466. Quantitative 2D 1H, 13C HSQC NMR spectroscopy for the determination of chondroitin sulfate and dermatan sulfate content in danaparoid sodium. Gardini C., Boccardi G., Guerrini M., Kellenbach E., Lunenburg M., van der Meer JY., Naggi A., Urso E. Thromb Haemost 2023 DOI

465. Analysis of Heparin Samples by Attenuated Total Reflectance Fourier-Transform Infrared Spectroscopy in the Solid State. Devlin A.J., Mycroft-West C.J., Turnbull J.E., Lima M.A., Guerrini M., Yates E.A., Skidmore M.A. ACS central 2023,

464. A sulphated glycosaminoglycan extract from Placopecten magellanicusinhibits the Alzheimer’s disease β-Site amyloid precursor protein cleaving enzyme 1 (BACE-1). Mycroft -West C.J., Devlin A.J., Cooper L.C., Guimon S.E., Procter P., Miller, G.J., Guerrini M., Fernig D.G., Yates E.A., Lima M.A., Skidmore M.A. Carbohydr. Res. 2023, 525, 108747.

463. Evidence for multiple binding modes in the initial contact between SARS-CoV-2 spike S1 protein and cell surface glycans. Parafioriti M., Ni M., Petitou M., Mycroft-West C.J., Rudd T.R., Gandhi N. S., Ferro V., Turnbull J. E., Lima M.A., Skidmore M. A., Fernig G., Yates E.A., Bisio A., Guerrini M., Elli S. Chem Eu. J. 2023, 29, e2022025

462. Chitosan-based coatings with tunable transparency and superhydrophobicity : A solvent-free and fluorine-free approach by steroyl derivatization, Tagliaro I., Seccia S., Pellegrini B., Bertini S., Antonini C.,  Carbohydrate Polymers, 2023,

461. 3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans Cadamuro F., Marongiu L., Marino M., ` Tamini N., Nespoli L., Zucchini N., Terzi A., Altamura D., Gao Z., Giannini C., Bindi G., Smith A., Magni F., Bertini S., Granucci F., Nicotra F., Russo L.,  Carbohydrate Polymers, 2023, 120395.

460. Further advances in identification of pentosan polysulfate monosaccharide composition by NMR Eisele G., Alekseeva A., Bertini B., Gardini C., Paganini D., Montatixe Fonseca E. C., Guerrini M., Naggi A, , Journal of Pharmaceutical and Biomedical Analysis 235 (2023) 115672.

459. Carbohydrate-based antithrombotics. In “Carbohydrate-Based Therapeutics” Bisio A., Guerrini G., Naggi A., Adamo R. and Lay L. Eds Wiley-VCH, Weinheim, 353-380 (2023)

458. Glycosaminoglycans: What Remains to be Deciphered?  Perez S., Mashkakova O, Angulo J., Bedini E., Bisio A., de Paz J.L., Fadda E., Guerrini M., Hricovini M., Hricovini M., Lisacek F., Nieto P., Pagel K., Paiardi G., Richter R., Samsonov S., Vives R., Nikitovic D., Ricard-Blum S. JACS Au  PMC10052243 

457. Heparin-Superparamagnetic Iron Oxide Nanoparticles for Theranostic Applications. Massironi N, Colombo M, Cosentino C, Fiandra L, Mauri M, Kayal Y, Testa F, Torri G, Urso E, Vismara E, Vlodavsky I. Molecules 2022 27(20):7116 https://doi.10.3390/molecules27207116  

456. Thermodynamic insight on the effects of low-molecular weight heparins on Antithrombin III. Saitta F., Masuri J., Signorelli M., Bertini S., Bisio A., Fessas D. 2022, Thermochim. Acta.   

455. Structural variation in the linkage region of pharmaceutical heparin arising from oxidative treatments during manufacture. Urso E., Mantione G., Sala F., Yates E.A., Guerrini M., Naggi A. Carbohydr. Res. 514 (2022). 

454. NMR spectroscopy and chemometric models to detect a specific non-porcine ruminant contaminant in pharmaceutical heparin. Colombo E., Mauri L., Marinozzi M., Rudd T.R., Yates E.A., Ballabio D., Guerrini M. 2022 J. Pharm. Biomed. Anal. 214, 114724 

453. Initial contact between SARS-CoV-2 spike S1 protein and cell surface glycans involves multiple binding modes. Parafioriti M., Ni M., Petitou M., Mycroft-West M.J., Rudd T.R., Gandhi N.S., Ferro V., Turnbull J.E., Lima M.A., Skidmore M.A., Fernig D.G., Yates E.A., Bisio A., Guerrini M., and Elli S. ChemRχiv. 2022, DOI: 10.26434/chemrxiv-2022-21brb  

452. Pentosan polysulfate inhibits attachment and infection by SARS-CoV-2 in vitro: insights into structural requirements for binding. Bertini S., Alekseeva A., Elli S., Pagani I., Zanzoni S., Eisele G., Krishnan R., Maag K.P., Reiter C., Lenhart D., Gruber R., Yates E.A., Vicenzi E., Naggi A., Bisio A., Guerrini M. 2022 Thromb. Haemost. 122, 867-880.     

451. Professor Casu’s contribution to cyclodextrins, the remarkable cage-shape molecules: a review. Torri G., Naggi A., Lichtfouse E., Crini G. 2022 Environ. Chem. Letters 

450. Suspended Multifunctional Nanocellulose as Additive for Mortars. Diamanti M.V., Tedeschi C., Taccia M.; Torri G., Massironi N., Tognoli C., Vismara E. Nanomaterials 2022,12, 1093. 

449. Prevention of triglyceridemia by (non-) anticoagulant heparin (oids) does not preclude transplant vasculopathy and glomerulosclerosis. Shrestha, P., Katta, K., Talsma, D., Naggi, A., Hillebrands, J. L., van de Sluis, B., & Van Den Born, J. (2022). Frontiers in cell and developmental biology, 10. 

448. Innovative technologies to remove alkylphenols from wastewater: a review Crini, G., Cosentino, C., Bradu, C., Fourmentin, M., Torri, G., Ruzimuradov, O., … & Morin-Crini, N. (2022. Environmental Chemistry Letters, 1-32. 

447. Worldwide cases of water pollution by emerging contaminants: a review Morin-Crini, N., Lichtfouse, E., Liu, G., Balaram, V., Ribeiro, A. R. L., Lu, Z., G. Torri, … & Crini, G. (2022). Environmental Chemistry Letters, 1-28. 

446. Removal of emerging contaminants from wastewater using advanced treatments. A review. Morin-Crini, N., Lichtfouse, E., Fourmentin, M., Ribeiro, A. R. L., Noutsopoulos, C., Mapelli, F., G. Torri… & Crini, G. (2022). Environmental Chemistry Letters, 1-43.